|Bid||297.00 x 0|
|Ask||515.00 x 0|
|Day's range||297.70 - 307.70|
|52-week range||288.30 - 506.80|
|Beta (3Y monthly)||1.35|
|PE ratio (TTM)||N/A|
|Earnings date||14 Nov 2019|
|Forward dividend & yield||0.08 (2.32%)|
|1y target est||448.00|
If you want to know who really controls Mediclinic International plc (LON:MDC), then you'll have to look at the makeup...
In this article we are going to estimate the intrinsic value of Mediclinic International plc (LON:MDC) by estimating...
Mediclinic International Plc, reported a 4% fall in full-year core profit on Thursday, in line with market expectations, hit by regulatory changes for its Swiss business. Mediclinic, which also has operations in southern Africa and the Middle East, has faced stricter regulations in Switzerland that have hobbled growth and put pressure on margins. "The operating performance was impacted by the lower contribution from Hirslanden (Swiss), offset by an improved performance in the second half of the financial year from Mediclinic Southern Africa and Mediclinic Middle East," the firm said in a statement.
Shares in Mediclinic International hit a more than three-month high on Wednesday after it reassured investors with a forecast for net profit that was in line with market expectations despite a tough business backdrop. "Today's trading update will restore some lost confidence," RMB Morgan Stanley equity analyst Roy Campbell said in a note after the private healthcare group forecast an expected 3.5 percent fall in earnings before interest, tax, depreciation and amortization (EBITDA) for the full-year ended March 2019. Mediclinic's reported EBITDA for the year ending March 2018 was 515 million pounds ($673 million).
Mediclinic International Plc said it expects full-year group core profit to fall by 3.5 percent, in line with market expectations in a challenging healthcare environment. Financial year 2018 earnings before ...
It is not uncommon to see companies perform well in the years after insiders buy shares. On the other hand, we'd be remiss not to mention that insider sales have been known to precede tough periods for a business. So before you buy or...
Mediclinic International (LSE: MDC.L - news) Plc plans to reduce capex for its Swiss business, open more outpatient surgery units and medical centres in order to mitigate regulatory challenges in Switzerland's healthcare market. A constituent of London's FTSE 100 index with a secondary listing in Johannesburg, Mediclinic has faced stricter regulations this year in Switzerland that have hobbled growth and put pressure on margins.
JOHANNESBURG, Oct (Shenzhen: 000069.SZ - news) 17 (Reuters) - Mediclinic on Wednesday flagged an 8 percent drop in core profit for the first six months of the year, sending its shares tumbling 19 percent. The private hospital group, which is listed in London and Johannesburg, blamed weaker-than-expected growth in admissions in Switzerland and a slow second quarter in Southern Africa. Group adjusted core profit, or EBITDA, would fall to 214 million pounds ($282 million) versus 232 million pounds in the same period a year ago.